Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Free access | 10.1172/JCI89436

WNT signaling determines tumorigenicity and function of ESC-derived retinal progenitors

Lu Cui, Yuan Guan, Zepeng Qu, Jingfa Zhang, Bing Liao, Bo Ma, Jiang Qian, Dangsheng Li, Weiye Li, Guo-Tong Xu, and Ying Jin

Find articles by Cui, L. in: JCI | PubMed | Google Scholar

Find articles by Guan, Y. in: JCI | PubMed | Google Scholar

Find articles by Qu, Z. in: JCI | PubMed | Google Scholar

Find articles by Zhang, J. in: JCI | PubMed | Google Scholar

Find articles by Liao, B. in: JCI | PubMed | Google Scholar

Find articles by Ma, B. in: JCI | PubMed | Google Scholar

Find articles by Qian, J. in: JCI | PubMed | Google Scholar

Find articles by Li, D. in: JCI | PubMed | Google Scholar

Find articles by Li, W. in: JCI | PubMed | Google Scholar

Find articles by Xu, G. in: JCI | PubMed | Google Scholar

Find articles by Jin, Y. in: JCI | PubMed | Google Scholar

Published October 3, 2016 - More info

Published in Volume 126, Issue 10 on October 3, 2016
J Clin Invest. 2016;126(10):4061–4061. https://doi.org/10.1172/JCI89436.
Copyright © 2016, American Society for Clinical Investigation
Published October 3, 2016 - Version history
View PDF

Related article:

WNT signaling determines tumorigenicity and function of ESC-derived retinal progenitors
Lu Cui, … , Guo-Tong Xu, Ying Jin
Lu Cui, … , Guo-Tong Xu, Ying Jin
Research Article Article has an altmetric score of 27

WNT signaling determines tumorigenicity and function of ESC-derived retinal progenitors

  • Text
  • PDF
Abstract

Tumor formation constitutes a major obstacle to the clinical application of embryonic stem cell–derived (ESC-derived) cells. In an attempt to find major extracellular signaling and intrinsic factors controlling tumorigenicity and therapeutic functionality of transplanted ESC-derived retinal progenitor cells (ESC-RPCs), we evaluated multiple kinds of ESC-RPCs in a mouse retinal degeneration model and conducted genome-wide gene expression profiling. We identified canonical WNT signaling as a critical determinant for the tumorigenicity and therapeutic function of ESC-RPCs. The function of WNT signaling is primarily mediated by TCF7, which directly induces expression of Sox2 and Nestin. Inhibition of WNT signaling, overexpression of dominant-negative Tcf7, and silencing Tcf7, Sox2, or Nestin all resulted in drastically reduced tumor formation and substantially improved retinal integration and visual preservation in mice. These results demonstrate that the WNT signaling cascade plays a critical role in modulating the tumorigenicity and functionality of ESC-derived progenitors.

Authors

Lu Cui, Yuan Guan, Zepeng Qu, Jingfa Zhang, Bing Liao, Bo Ma, Jiang Qian, Dangsheng Li, Weiye Li, Guo-Tong Xu, Ying Jin

×

Original citation: J Clin Invest. 2013;123(4):1647–1661. doi:10.1172/JCI65048.

Citation for this corrigendum: J Clin Invest. 2016;126(10):4061. doi:10.1172/JCI89436.

In Figure 4D, the merged image showing fTCF7, NESTIN, and BrdU staining of Vector-ESC-RPCs and the merged image showing SOX2, PCNA, and BrdU staining of ΔNTcf7-ESC-RPCs were mislabeled. The correctly labeled images are below.

The authors regret the error.

Footnotes

See the related article beginning on page 1647.

Version history
  • Version 1 (October 3, 2016): Print issue publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Posted by 3 X users
Referenced in 7 patents
On 3 Facebook pages
63 readers on Mendeley
See more details